Dr William Kevin Wright, OD in Alton, IL - Medicare Optometry Provider

Dr William Kevin Wright, OD is a medicare enrolled "Optometrist" provider in Alton, Illinois. He went to University Of Houston - College Of Optometry and graduated in 1984 and has 40 years of diverse experience with area of expertise as Optometry. He is a member of the group practice Pec Alton Llc and his current practice location is 2865 Homer M Adams Pkwy, Alton, Illinois. You can reach out to his office (for appointments etc.) via phone at (618) 465-1654.

Dr William Kevin Wright is licensed to practice in Illinois (license number ) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1790894673.

Contact Information

	Dr William Kevin Wright, OD
	2865 Homer M Adams Pkwy, Alton, IL 62002-4856
	(618) 465-1654
	(618) 465-8652

Healthcare Provider's Profile

Full Name	Dr William Kevin Wright
Gender	Male
Speciality	Optometry
Experience	40 Years
Location	2865 Homer M Adams Pkwy, Alton, Illinois
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr William Kevin Wright attended and graduated from University Of Houston - College Of Optometry in 1984

NPI Data:

NPI Number: 1790894673
Provider Enumeration Date: 08/30/2006
Last Update Date: 04/18/2008

Medicare PECOS Information:

PECOS PAC ID: 2860597804
Enrollment ID: I20070419000203

Medical Identifiers

Medical identifiers for Dr William Kevin Wright such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1790894673	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	T02601 (Missouri)	Secondary
152W00000X	Optometrist	(Illinois)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Pec Alton Llc	7416240130	2

News Archive

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Today, the U.S. Food and Drug Administration announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years.

Personal intervention reduces drinking among risky college drinkers

Brief but personal intervention reduces drinking among risky college drinkers, according to a research study at The University of Texas School of Public Health.

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

DURECT Corporation announced today results from a European Phase IIb hysterectomy clinical trial conducted by Nycomed of POSIDUR™ (also known as SABER™-bupivacaine or Optesia™ in the E.U.), a proprietary product under development for the treatment of post-surgical pain.

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduced the risk of cardiovascular death, heart attack or stroke within 30 days following the procedure, according to an article in the September 14 issue of JAMA: The Journal of the American Medical Association.

REPEL-CV approved for cardiac surgeries

SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr William Kevin Wright allows following entities to bill medicare on his behalf.

Provider Name	Pec Alton Llc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1598114001 PECOS PAC ID: 7416240130 Enrollment ID: O20160718002458

News Archive

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Personal intervention reduces drinking among risky college drinkers

Brief but personal intervention reduces drinking among risky college drinkers, according to a research study at The University of Texas School of Public Health.

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

REPEL-CV approved for cardiac surgeries

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr William Kevin Wright is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr William Kevin Wright, OD 2865 Homer M Adams Pkwy, Alton, IL 62002-4856 Ph: (618) 465-1654	Dr William Kevin Wright, OD 2865 Homer M Adams Pkwy, Alton, IL 62002-4856 Ph: (618) 465-1654

News Archive

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Personal intervention reduces drinking among risky college drinkers

Brief but personal intervention reduces drinking among risky college drinkers, according to a research study at The University of Texas School of Public Health.

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

REPEL-CV approved for cardiac surgeries

Optometrist in Alton, IL

Aeg Delaware Professional Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 111 E 4th St Ste 440, Alton, IL 62002 Phone: 618-462-9818
Aeg Connecticut Professional Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 111 E 4th St Ste 440, Alton, IL 62002 Phone: 618-462-9818 Fax: 314-741-4947
Dr. James Walter Lieber, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 401 Henry St, Alton, IL 62002 Phone: 618-465-6000
Mark D. Wade O D P C Optometrist Medicare: Not Enrolled in Medicare Practice Location: 111 E 4th St Ste 440, Alton, IL 62002 Phone: 618-462-9818 Fax: 314-741-4947
Crown Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 111 E 4th St Ste 440, Alton, IL 62002 Phone: 618-462-9818 Fax: 314-741-4947
Clarkson Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1819 Homer Adams Parkway, Suite B, Alton, IL 62002 Phone: 636-200-4393 Fax: 636-938-2650
Pearle Vision Of Alton, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2865 Homer M Adams Pkwy, Alton, IL 62002 Phone: 618-465-1654 Fax: 618-465-8652

Dr William Kevin Wright, OD - Medicare Optometrist in Alton, IL

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Personal intervention reduces drinking among risky college drinkers

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

REPEL-CV approved for cardiac surgeries

Medicare Reassignments

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Personal intervention reduces drinking among risky college drinkers

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

REPEL-CV approved for cardiac surgeries

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

Personal intervention reduces drinking among risky college drinkers

DURECT reports European POSIDUR Phase IIb hysterectomy clinical trial results

Use of the antiplatelet drug clopidogrel before a coronary angioplasty reduces risk of cardiovascular death

REPEL-CV approved for cardiac surgeries

Optometrist in Alton, IL